Small fiber neuropathy is the diagnosis most often missed in people whose feet burn. The symptoms are severe, the standard nerve test is frequently normal, and the patient is sent home with the impression that nothing was found. Nothing was found because the test that was run does not look at the fibers that are damaged.
This article covers what the symptoms actually are, how the condition is properly tested for, and why the cause — in a large share of cases — turns out to be metabolic.
What “small fiber” means
Peripheral sensory nerves come in two calibers. Large myelinated fibers carry vibration, light touch, position sense and the signals behind your ankle reflexes. Small fibers — thinly myelinated A-delta and unmyelinated C fibers — carry pain, temperature, and the autonomic traffic that controls sweating, blood vessel tone and internal organ function.1
Small fibers are the most metabolically exposed part of the system. They are unmyelinated or barely myelinated, they terminate in the skin far from their cell bodies, and they depend on the smallest blood vessels in the body. When the metabolic environment deteriorates, they fail first — and they fail at the toes first, because that is where the longest ones end.
The symptoms
Sensory symptoms
- Burning feet, the most characteristic complaint, typically worse at night and worse at rest
- Pins and needles, prickling or tingling that does not resolve with movement
- Sharp, stabbing or electric pain in bursts
- Allodynia — the weight of bedding on the toes registering as pain
- Altered temperature sensation, where cold feels burning or hot water cannot be judged reliably
- A sense of walking on pebbles, sand, or bunched socks that are not there
The distribution is symmetrical and length-dependent: toes first, then feet, then ascending the legs over months to years, with the hands involved only much later.
Autonomic symptoms
This is the half that rarely gets connected to the feet, because the symptoms appear elsewhere in the body and get reported to different specialists:
- Reduced or absent sweating in the feet, leaving skin dry, cracked and shiny — or, less often, excessive sweating elsewhere
- Lightheadedness on standing from impaired blood vessel constriction
- Color and temperature changes in the feet — mottling, redness, or feet that feel cold to you and warm to the touch
- Gastrointestinal changes: early fullness after eating, bloating, constipation or diarrhea
- Bladder changes and erectile dysfunction
- Dry eyes and dry mouth
When burning feet and several of these appear together, small fiber neuropathy is a far better explanation than five unrelated diagnoses.1
What is usually absent
Pure small fiber neuropathy generally spares strength, vibration sense and reflexes. Normal ankle reflexes and normal strength do not argue against the diagnosis — they are what the diagnosis predicts. Once weakness, lost vibration sense and absent reflexes appear, large fibers have been recruited into the process as well.
Why standard nerve testing comes back normal
Nerve conduction studies and electromyography measure large myelinated fibers. Small fibers are, by definition, not what those studies record. A patient with pure small fiber neuropathy can have severe nightly burning and an entirely normal electrodiagnostic study.1
This is worth being precise about, because a normal result is often reported to the patient as reassurance. It is not reassurance. It is a negative finding on a test aimed elsewhere. The correct interpretation is that large fibers are intact, which is useful information — it makes small-fiber-predominant disease more likely, not less.
Electrodiagnostic testing still belongs in the workup. It rules out large-fiber involvement, identifies coexisting nerve compression, and establishes a baseline. At Regenerve it is performed on site, and it is always interpreted alongside the history, the examination and the search for a cause.

How small fiber neuropathy is confirmed
The reference standard is a 3 mm punch skin biopsy from the distal leg, with intraepidermal nerve fiber density counted against age- and sex-matched normative values. The European Federation of Neurological Societies and Peripheral Nerve Society guideline rates this as a reliable and efficient method of confirming the diagnosis.2 It is a small procedure done under local anesthetic, and it produces a number that can be repeated later to measure change.
Two other tests appear in the workup. Quantitative sensory testing measures thermal and pain thresholds, and quantitative sudomotor axon reflex testing measures sweat responses driven by the small autonomic fibers.1 Both add information; neither replaces the biopsy.
The cause is metabolic more often than “idiopathic”
A large proportion of small fiber neuropathy has historically been labeled idiopathic. Much of that label reflects incomplete testing.
When 107 consecutive patients with idiopathic neuropathy were given a two-hour oral glucose tolerance test, 36 of them — 34% — had impaired glucose tolerance, nearly three times the rate in age-matched controls. Fasting glucose and HbA1c were frequently normal in those patients; the OGTT was the test that found it. The authors concluded that impaired glucose tolerance may cause or contribute to small-fiber neuropathy with a phenotype resembling the painful sensory neuropathy seen in diabetes.3
The story does not end at glucose. In a series of 219 patients with idiopathic neuropathy, those with completely normal blood sugar carried the same elevated burden of metabolic syndrome features as those with impaired glucose tolerance, and had significantly higher total and LDL cholesterol and more abnormal HDL and triglycerides than a comparison group with diabetes but no neuropathy.4
In other words: small fiber neuropathy tracks the metabolic terrain as a whole — glucose handling, lipids, blood pressure, central obesity and the microvascular supply — not any single laboratory value. Beyond the metabolic group, the differential includes autoimmune disease, B12 and other nutritional deficiencies, gluten-related nerve injury, thyroid disease, infections, toxic exposures, certain medications, and genetic sodium channel variants.1 The full list is in the 11 hidden drivers of peripheral neuropathy.
Small fibers can regrow
This is the part worth holding onto. Because small fiber density is measured in the skin, it can be measured again — and it moves.
Thirty-two patients with impaired glucose tolerance and neuropathy received individualized diet and exercise counseling for one year. Intraepidermal nerve fiber density improved by 1.4 fibers per millimeter at the proximal biopsy site, and the improvement correlated with reduced neuropathic pain.5 Separately, a 10-week supervised aerobic and resistance exercise program in patients with diabetic peripheral neuropathy produced significant reductions in pain and neuropathic symptoms alongside increased intraepidermal nerve fiber branching on biopsy.6
Both were small studies, and neither is a promise. But they demonstrate something that matters clinically: treating the metabolic environment produces measurable change in the nerve fibers themselves, not merely in how the patient rates their pain. That is the reasoning behind our approach, set out in the Regenerve Protocol. The training side is covered in exercises for peripheral neuropathy in the feet, and the supplement evidence — including alpha-lipoic acid, which has been studied in exactly this symptom set — is graded in alternative medicine for peripheral neuropathy.
What a proper evaluation should include
- A history and examination oriented to fiber type, not just to “does it hurt”
- Electrodiagnostic testing to define large-fiber status and exclude compression
- A two-hour oral glucose tolerance test, not a fasting glucose or HbA1c alone
- A full lipid panel, read as part of the neuropathy workup rather than a separate cardiac issue
- B12 with methylmalonic acid, thyroid studies, and screening for autoimmune and inflammatory causes
- Skin biopsy for intraepidermal nerve fiber density where the diagnosis needs confirming or quantifying
- A medication review, including statins and long-term metformin
Being evaluated in St. Louis
Regenerve is at 4477 Woodson Rd #104, St. Louis, MO 63134, minutes from St. Louis Lambert International Airport, and is led by Dr. Gurpreet Singh Padda, MD, MBA, MHP. The practice serves the St. Louis region, Missouri and Illinois.
Call or text (314) 886-5902, or email info@regenerve.com. Office hours are Monday through Thursday 9:00 to 16:00 and Friday 9:00 to 13:30. Details are on the contact page and the locations page.
If a nerve test came back normal and your feet still burn, the Nerve Damage Score is a five-question assessment that produces a large-print report you can bring to any physician.
Frequently asked questions
What are the symptoms of small fiber peripheral neuropathy?
Burning feet that are worse at night, prickling and stabbing pain, pain from light touch such as bedding, altered temperature sensation, and autonomic symptoms including reduced sweating in the feet, lightheadedness on standing and gastrointestinal changes. See peripheral neuropathy of the feet symptoms.
Is “small fibre neuropathy” the same as small fiber neuropathy?
Yes. “Small fibre” is the British spelling of the same condition; the diagnosis, testing and treatment are identical. See the hidden drivers of peripheral neuropathy.
Can small fiber neuropathy show up with a normal EMG and nerve conduction study?
Yes, and it commonly does. Those studies measure large myelinated fibers, so a pure small fiber neuropathy can produce severe symptoms with a normal result. See which specialist you should see.
How is small fiber neuropathy diagnosed?
By a 3 mm punch skin biopsy from the distal leg with intraepidermal nerve fiber density counted against normative values, supported by quantitative sensory and sudomotor testing. See the Regenerve Protocol.
What causes small fiber neuropathy?
Metabolic causes lead. About a third of patients labeled idiopathic have impaired glucose tolerance that fasting glucose and HbA1c missed, and even normoglycemic patients carry a high burden of metabolic syndrome features, particularly abnormal lipids. See how sugar damages nerves.
Can small nerve fibers grow back?
They can. Diet and exercise counseling over one year increased intraepidermal nerve fiber density on skin biopsy, and the increase correlated with less neuropathic pain. Recovery is partial and slow, and no one can promise a cure. See exercises for peripheral neuropathy in the feet.
Sources
- Terkelsen AJ, et al. The diagnostic challenge of small fibre neuropathy: clinical presentations, evaluations, and causes. The Lancet Neurology. 2017. PMID 29029847
- Lauria G, et al. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fibre neuropathy. European Journal of Neurology. 2010. PMID 20642627
- Singleton JR, Smith AG, Bromberg MB. Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy. Diabetes Care. 2001. PMID 11473085
- Smith AG, Rose K, Singleton JR. Idiopathic neuropathy patients are at high risk for metabolic syndrome. Journal of the Neurological Sciences. 2008. PMID 18606421
- Smith AG, et al. Lifestyle intervention for pre-diabetic neuropathy. Diabetes Care. 2006. PMID 16732011
- Kluding PM, et al. The effect of exercise on neuropathic symptoms, nerve function, and cutaneous innervation in people with diabetic peripheral neuropathy. Journal of Diabetes and its Complications. 2012. PMID 22717465